Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
This genomic entity is a **pseudogene** related to the gene encoding *small nuclear ribonucleoprotein polypeptide B* (SNRPB2). Pseudogenes are segments of DNA similar to known genes but generally non-functional due to mutations, truncations, or lack of regulatory elements. While once thought to be biologically inert, pseudogenes can regulate the expression of their parental genes through several mechanisms at the RNA level: - Acting as competitive endogenous RNAs (ceRNAs) by sequestering microRNAs (miRNAs) and modulating the post-transcriptional regulation of the parent gene or other genes with shared miRNA response elements[4][6]. - Producing antisense RNAs, small interfering RNAs (siRNAs), or long noncoding RNAs (lncRNAs) influencing transcriptional or post-transcriptional regulation of functional genes[4][6]. - In rare instances, some pseudogenes may be translated into short peptides, potentially presented as antigens, but this is generally not established for this specific pseudogene[6]. The **ENSG00000229668** gene is annotated as a pseudogene and not a protein-coding gene or characterized receptor, enzyme, transporter, or other drug target[3]. There is no evidence for this locus being a drug target, possessing known drug interactions, or being used in clinical biomarker or therapeutic contexts. Furthermore, pseudogenes by definition are not conventional therapeutic targets and information for this entity is for research or annotation purposes only.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Pseudogene similar to part of small nuclear ribonucleoprotein polypeptide B.